Evidence map›Paper›PMID 38095449›Full record

ArticlemSystems2024

Poly-omic risk scores predict inflammatory bowel disease diagnosis.

Christopher H Arehart, John D Sterrett, Rosanna L Garris, Ruth E Quispe-Pilco, Christopher R Gignoux, Luke M Evans, Maggie A Stanislawski

Abstract read
In one paragraph

Article in mSystems, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Christopher H Arehart *Interdisciplinary Quantitative Biology PhD Program, University of Colorado, Boulder, Colorado, USA.ORCID 0009-0001-9575-8329
John D Sterrett *Interdisciplinary Quantitative Biology PhD Program, University of Colorado, Boulder, Colorado, USA.ORCID 0000-0002-0931-7181
Rosanna L GarrisInterdisciplinary Quantitative Biology PhD Program, University of Colorado, Boulder, Colorado, USA.
Ruth E Quispe-PilcoInterdisciplinary Quantitative Biology PhD Program, University of Colorado, Boulder, Colorado, USA.
Christopher R GignouxDepartment of Biomedical Informatics, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
Luke M EvansDepartment of Ecology and Evolutionary Biology, University of Colorado, Boulder, Colorado, USA.
Maggie A StanislawskiDepartment of Biomedical Informatics, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.

Funding

PILOT STUDY--SUBSTRATE METABOLISM IN EXTREMELY LOW BIRTH WEIGHT INFANTSP30DK048520 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI Edward L Melanson · 1995 to 2026
$32.6M
Research Training: Mental Health Behavior GeneticsT32MH016880 · NIMH · UNIVERSITY OF COLORADO AT BOULDER · PI Naomi P. Friedman, Matthew Charles Keller · 1985 to 2026
$5.3M
The Contribution of Omic Profiles to Weight Loss and ObesityK01HL157658 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI Maggie A Stanislawski · 2022 to 2026
$794k
NHLBI NIH HHS K01 HL157658NIMH NIH HHS T32 MH016880
6 · The paper itself

Abstract

Inflammatory bowel disease (IBD) is characterized by complex etiology and a disrupted colonic ecosystem. We provide a framework for the analysis of multi-omic data, which we apply to study the gut ecosystem in IBD. Specifically, we train and validate models using data on the metagenome, metatranscriptome, virome, and metabolome from the Human Microbiome Project 2 IBD multi-omic database, with 1,785 repeated samples from 130 individuals (103 cases and 27 controls). After splitting the participants into training and testing groups, we used mixed-effects least absolute shrinkage and selection operator regression to select features for each omic. These features, with demographic covariates, were used to generate separate single-omic prediction scores. All four single-omic scores were then combined into a final regression to assess the relative importance of the individual omics and the predictive benefits when considered together. We identified several species, pathways, and metabolites known to be associated with IBD risk, and we explored the connections between data sets. Individually, metabolomic and viromic scores were more predictive than metagenomics or metatranscriptomics, and when all four scores were combined, we predicted disease diagnosis with a Nagelkerke's

Indexed as

Inflammatory Bowel DiseasesMicrobiotaHumansMetagenomicsPhenotypeRisk Factorsgut microbiomeinflammatory bowel diseasemetabolomicsmetatranscriptomicsmulti-omicsomicsviromics

Identifiers

PMID38095449
PMCPMC10805030

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.